News

A 2-week old Ebola outbreak in the DRC has already surpassed the previous outbreak

The results of a study published by JAMA Internal Medicine are a call to action for cities facing homelessness crises.

A new report from researchers at the Centers for Disease Control and Prevention details the investigational use of a drug to treat Chagas disease now available commercially in the United States.

The CDC now recommends that men who have been exposed to Zika use condoms or abstain from sex for 3 months to prevent sexual transmission of Zika.

The PDUFA action date has been set for February 13, 2019.

As health care services move into the outpatient setting, is infection control being overlooked?

Several outbreaks of mumps in university settings throughout Indiana in 2016 highlight a need for standardized immunization record collection and a third MMR vaccination dose for individuals at increased risk of infection.

Small studies show good outcomes for previously uninfected recipients who receive kidneys from donors infected with hepatitis.

We’re rounded up a list of recalls issued by the US Food and Drug Administration (FDA) from this past week.

In addition to over 100 cases across the country, the first case of WNV infection for 2018 was just reported in Contagion®’s home base of New Jersey.

The method uses genetic sequencing to pinpoint the source of new infections following a community intervention, therefore measuring the impact of the intervention.

A species of tick that is native to Australia, New Zealand, and eastern Asia, has been springing up in several US states this summer.

Investigators who evaluated the death of a 78-year-old man following a blood transfusion say there’s little that could have been done to prevent the infection.

NIH researchers discovered that norovirus and rotavirus can be transmitted through cloaked viral clusters which exacerbate the spread and severity of disease.

The FDA approves tafenoquine tablets for the prevention of malaria in patients aged 18 and older.

The combination of direct-acting antiviral agents glecaprevir/pibrentasvir (G/P), sofosbuvir, and ribavirin is now approved for new patient populations.

The FDA advisory committee voted 17 to 1 in favor of omadacycline for treatment of ABSSSI and 14 to 4 for the treatment of CABP.

The CDC reports that 1 in 7 infants exposed to Zika during pregnancy developed a birth defect or abnormality related to the virus.

If approved, ALIS will be the first and only therapy available in the United States that will be specifically indicated for the treatment of patients with NTM lung disease caused by MAC.

The storm compromised the island’s medical infrastructure, interrupting treatment of chronic diseases and disrupting testing for infectious disease outbreaks.

In a new study, researchers from New York City’s Department of Health and Mental Hygiene say that a 2013 measles outbreak that sprung up in the city was linked to vaccine refusal.

Researchers in Slovenia investigate why some Lyme disease patients respond more quickly to treatment than others.

Investigators report that the duration of viral shedding of influenza A in obese adults was 42% longer than nonobese adults.

New research suggests 4 months of rifampin produced higher rates of adherence than 9 months of isoniazid in individuals with latent tuberculosis.

Fidaxomicin and vancomycin are effective first-line therapies for Clostridium difficile, yet fidaxomicin may be more effective for achieving sustained symptomatic cure.

With vaccine efficacy during the 2017–2018 flu season under question, a novel antiviral agent may provide a solution.

We’ve compiled a list of product recalls issued by the US Food and Drug Administration (FDA) from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.